Nvidias Record Earnings Fail to Soothe Investor Concerns on Growth Outlook LIC HDFC Bank Lead Seven Top Movers in Wednesday Trading Vincent Bollors Media Influence Sparks Debate Over Democracy at Cannes Film Festival Jay Thakkar Recommends Three FO Stocks for ShortTerm as Nifty Faces Resistance at 24100 SP 500 Claws Higher as Healthcare and Tech Rally Communication Services Lags Spanish Brewer Hijos de Rivera Establishes Italian Subsidiary to Bolster European Presence Talkspace Inc Q1 2026 Earnings EPS Misses Estimates Revenue Not Disclosed FLNG Q1 2026 Earnings EPS Misses Estimates Amid Challenging LNG Shipping Market EU Q1 2026 Earnings EPS Surprises to the Upside Turning Profit on Higher Uranium Production AEON Q4 2025 Earnings WiderThanExpected Loss as Biotech Continues PreRevenue Phase PPHC Q4 2025 Earnings EPS Surges Past Estimates by Over 20 Yet Stock Slips Beasley Broadcast Group Inc Q4 2025 Earnings Significant EPS Loss Amid Operational Headwinds Twin Disc TWIN Gains 050 as Stock Tests Technical Resistance MFAO Holds Steady Near 2520 as Senior Notes Trade in Tight Range Barings Corporate Investors MCI Gains 253 as Shares Approach Key Resistance Level Kayne Anderson Energy Infrastructure Fund KYN Faces Slight Pullback as Energy Sector Volatility Persists ECARX Holdings Warrants ECXWW Remain Flat at 005 Amid Low Volume Former SNP Chief Executive Pleads Guilty to Embezzling 400000 in Party Funds IGC Pharma Q1 2026 Earnings Narrower Loss Beats Estimates Shares Edge Lower RELX RELX Edges Lower Near 3285 as Shares Consolidate Between Key Levels XFLH Capital Corporation XFLH Holds Steady at 1022 as Key Levels Define Trading Range Calamos Dynamic Convertible Income Fund CCD Shows Resilience Uptick Amid Mixed Market Sentiment QuantumSi QSI Surges 7 as Shares Test Key Resistance Level Bobs Discount Furniture BOBS Navigates Tight Trading Range Amid Modest Decline MacroGenics MGNX Surges 684 Biotech Stock Approaches Key Resistance at 476 Comcast Holdings ZONES CCZ Holds Steady at 639 as Consolidation Continues AUTL Flatlines at 168 Autolus Therapeutics Consolidates Near Key Support